Abstract
No public abstract is available from the verified source records.
Giacomo Spano, Michail Kastellorizios
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Cancer statistics, 2025
2025
Breast cancer statistics 2024
2024
Health and racial disparity in breast cancer
10.1007/978-3-030-20301-6_3 · 2019
Racial/ethnic disparities in risk of breast cancer mortality by molecular subtype and stage at diagnosis
10.1007/s10549-021-06311-7 · 2021
African American patients with breast cancer have worse prognosis than white patients in certain subtypes and stages
10.1007/s10549-017-4484-1 · 2017
Disparities in breast cancer characteristics and outcomes by race/ethnicity
10.1007/s10549-010-1191-6 · 2011
Cancer pharmacoethnicity: ethnic differences in susceptibility to the effects of chemotherapy
10.1158/1078-0432.ccr-09-0344 · 2009
Analyses of repeated failures in cancer therapy for solid tumors: poor tumor-selective drug delivery, low therapeutic efficacy and unsustainable costs
10.1186/s40169-018-0185-6 · 2018
Challenging the status quo to improve the translational potential of preclinical oncology studies
10.1038/s41568-024-00756-w · 2025
The role of the extracellular matrix and its molecular and cellular regulators in cancer cell plasticity
10.3389/fonc.2018.00431 · 2018
Drug resistance and the solid tumor microenvironment
10.1093/jnci/djm135 · 2007
Extracellular matrix and its therapeutic potential for cancer treatment
10.1038/s41392-021-00544-0 · 2021
Recent advances and clinical translation of liposomal delivery systems in cancer therapy
10.1016/j.ejps.2023.106688 · 2024
Improving the distribution of Doxil® in the tumor matrix by depletion of tumor hyaluronan
10.1016/j.jconrel.2014.05.019 · 2014
Doxil®–the first FDA-approved nano-drug: lessons learned
10.1016/j.jconrel.2012.03.020 · 2012
Modernizing preclinical drug development: the role of new approach methodologies
10.1021/acsptsci.5c00162 · 2025
Physicochemical and surface properties of nanoparticles: effects on cellular pathway and uptake
10.1002/cnma.202500043 · 2025
Alternative experimental approaches to reduce animal use in biomedical studies
10.1016/j.jddst.2022.103131 · 2022
Unresolved referenced work
Kept as external metadata until matched
The 3Rs and humane experimental technique: implementing change
2019
Three-dimensional in vitro tumor spheroid models for evaluation of anticancer therapy: recent updates
10.3390/cancers15194846 · 2023
Patient-derived organoids in human cancer: a platform for fundamental research and precision medicine
10.1186/s43556-023-00165-9 · 2024
Progress and promise of alternative animal and non-animal methods in biomedical research
10.1007/s00204-023-03532-1 · 2023
Contact angles and wettability: towards common and accurate terminology
10.1680/jsuin.17.00002 · 2017
Contact angle measurements: from existing methods to an open-source tool
10.1016/j.cis.2021.102470 · 2021
Effect of composition and size on surface properties of anti-cancer nanoparticles
10.3390/ijms241713417 · 2023
Novel method to obtain contact angles of tumor biopsies
10.1021/acsomega.3c01792 · 2023
Basic methods for preparation of liposomes and studying their interactions with different compounds, with the emphasis on polyphenols
10.3390/ijms22126547 · 2021
Sessile drop method: critical analysis and optimization for measuring the contact angle of an ion-exchange membrane surface
2022
Determination of contact angle of pharmaceutical excipients and regulating effect of surfactants on their wettability
2015
Unresolved referenced work
Kept as external metadata until matched
Decellularization for the retention of tissue niches
10.1177/20417314221101151 · 2022
Contribution of physical methods in decellularization of animal tissues
10.4103/jmss.jmss_2_20 · 2021
Fluorescence-based assays for measuring doxorubicin in biological systems
2016
A fluorescence study of the interaction of anticancer drug molecule doxorubicin hydrochloride in pluronic P123 and F127 micelles
10.1007/s10895-020-02630-y · 2021
Vesicle adsorption and lipid bilayer formation on glass studied by atomic force microscopy
10.1021/la049302v · 2004
Controlled-release, pegylation, liposomal formulations: new mechanisms in the delivery of injectable drugs
10.1345/aph.10054 · 2000
Change in the character of liposomes as a drug carrier by modifying various polyethyleneglycol-lipids
10.1248/bpb.b13-00084 · 2013
Correlation of fixed aqueous layer thickness around PEG-modified liposomes with in vivo efficacy of antitumor agent-containing liposomes
10.2174/157016311798109344 · 2011
Effects of the PEG molecular weight of a PEG-lipid and cholesterol on PEG chain flexibility on liposome surfaces
10.1016/j.colsurfa.2015.03.006 · 2015
10.1007/978-3-662-47039-8_15
10.1007/978-3-662-47039-8_15 · doi-reference
Polyethylene glycol immunogenicity in nanomedicine
10.1038/s44222-025-00321-6 · doi-reference
Surface-grafted polyethylene glycol conformation impacts the transport of PEG-functionalized liposomes through a tumour extracellular matrix model
10.1039/c7ra13438j · doi-reference
Extracellular matrix limits nanoparticle diffusion and cellular uptake in a tissue-specific manner
10.1021/acsnano.4c10381 · doi-reference
Extracellular matrix stiffness: mechanisms in tumor progression and therapeutic potential in cancer
10.1186/s40164-025-00647-2 · doi-reference
Extracellular matrix in the tumor microenvironment and its impact on cancer therapy
10.3389/fmolb.2019.00160 · doi-reference
Effects of poly(ethylene glycol) (PEG) chain length of PEG-lipid on the permeability of liposomal bilayer membranes
10.1248/cpb.51.815 · doi-reference